Health and Family Welfare Government Departments Closing in 12 days TDR #56486299

Tender For SUPPLY OF TABLETS, INJECTIONS MISCELLANEOUS ITEMS, YEAR- 2026-27-28 Part 5(Item No1401 TO 1433)

Issued by Government Departments · Vadodara, Gujarat
Tender Value
Ref. Documents
Estimated cost
Bid Submission
04 Aug 2026
12 days left
EMD
2.50 Lakhs
Bank guarantee accepted
Document Fee
5000
Non-refundable
Tender Type
Online

Tender Overview

Competition Type
NCB
Bidding Type
Tender
Location / State
Vadodara → Gujarat
EMD Exemption
Not Available
Quantity
Not Available

Project Description

SUPPLY OF TABLETS, INJECTIONS MISCELLANEOUS ITEMS, YEAR- 2026-27-28 Part 5(Item No1401 TO 1433)- triamcinolone injection 40 mg/ml (1 ml vial), triptorelin pamoate (11.25mg), triptorelin pamoate (22.5mg), trypan blue dye 0.06 percent w/v (1 ml oule), ultra long-acting basal insulin analogue inj (r-dna origin) insulin degludec 100iu/ml in 3ml pfs type of insulin:ultra long acting basa, vasopressin 20 units/ml, 1ml , vecuronium bromide injection 4 mg (iv use) (lyophilized), vedolizumab 300mg, velaglucerase alfa (r-dna origin), verapamil 10 mg, verapamil 5 mg/2 ml, vincristine sulphate lyophilized ip, vinorelbine concentrate, visco elastic substance (hydroxypropyl methyl cellulose ophthalmic solution usp) pfs 2.4 percent w/v 3 ml preservative free, vitamin b complex (for im use), 2 ml oule, vitamin b12 (mecobalamin) 1500 mcg/ml, vitamin b12 500 mcg/ml (cyanocobalamin injection), 1 ml oule, voriconazole 200mg/vial, zolendronic acid injection 4mg, human normal immunoglobulin and histamine dihydrochloride injection each ml contains:: - histamine dihydrochloride bp (0.15 mcg)- human normal immunoglobulin ip (12 mg)- sodium thiosulphate ip (32 mg)- water for injection ip (. qs)- stabilizer : maltose (in house) (7 percent )- pack sizes: 1ml in 2 ml vial /pfs- benzyl alcohol ip (1 percent ), human normal immunoglobulin i.p. 16.5 percent protein content (16.5 percent w/v)- stabilizer : glycine i.p. .. 0.3m (. )- preservative: thiomersal i.p. .... 0.01 percent w/v (. )- pack sizes: 1ml, 2ml and 5ml (. ), human prothrombin complex - 500 iu human prothrombin complex - 500 iu strength : each vial contains human coagulation factor ii - 280-760 iu human coagulation factor vii - 180 - 480 iu human coagulation factor ix - 500 iu human coagulation factor x -360 - 600 iu protein c - 260-620 iu protein s - 240-640 iupacking: vial, insulin glulisine prefillied pen, insulin glulisine cartrige, insulin glargine 300 iu/ml, human normal immunoglobulin and histamine dihydrochloride injection pfs each ml contains:: - histamine dihydrochloride bp (0.15 mcg)- human normal immunoglobulin ip (12 mg)- sodium thiosulphate ip (32 mg)- water for injection ip (. qs)- stabilizer : maltose (in house) (7 percent )- pack sizes: 1ml in 2 ml vial /pfs- benzyl alcohol ip (1 percent ) (2ml vial/pfs), human normal immunoglobulin i.p. 16.5 percent vial protein content (16.5 percent w/v)- stabilizer : glycine i.p. .. 0.3m (. )- preservative: thiomersal i.p. .... 0.01 percent w/v (. )- pack sizes: 1ml, 2ml and 5ml (. ) packing: vial, human prothrombin complex - 500 iu vialstrength : each vial contains human coagulation factor ii - 280-760 iu human coagulation factor vii - 180 - 480 iu human coagulation factor ix - 500 iu human coagulation factor x -360 - 600 iu protein c - 260-620 iu protein s - 240-640 iupacking: vial, anti hemophilic factor viii 250 iu (vwf) injection, anti hemophilic factor viii 500 iu (vwf) injection, anti hemophilic factor viii 1000 iu (vwf) injection, nafithromycin 400mg tab., nafithromycin 800mg tab.

BOQ

Sl. No. Item Name
1triamcinolone injection 40 mg/ml (1 ml vial)
2Triptorelin pamoate (11.25mg)
3Triptorelin pamoate (22.5mg)
4Trypan Blue Dye 0.06 Percent w/v (1 ml Ampoule)
5Ultra long-acting Basal Insulin analogue inj (r-DNA origin) Insulin degludec 100iu/ml in 3ml PFS Type of Insulin:Ultra Long Acting Basa
6Vasopressin 20 units/ml, 1ml Amp
7Vecuronium Bromide Injection 4 mg (IV use) (Lyophilized)
8Vedolizumab 300mg
9Velaglucerase Alfa (r-DNA Origin)
10Verapamil 10 mg
11Verapamil 5 mg/2 ml
12Vincristine sulphate lyophilized IP
13Vinorelbine Concentrate
14Visco Elastic substance (Hydroxypropyl Methyl Cellulose Ophthalmic Solution USP) PFS 2.4 Percent w/v 3 ml Preservative free
15Vitamin B Complex (For IM Use), 2 ml Ampoule
16Vitamin B12 (Mecobalamin) 1500 mcg/ml
17Vitamin B12 500 mcg/ml (Cyanocobalamin Injection), 1 ml Ampoule
18Voriconazole 200mg/vial
19Zolendronic Acid Injection 4mg
20Human Normal Immunoglobulin and Histamine Dihydrochloride Injection Each ml contains:: - Histamine Dihydrochloride BP (0.15 mcg)- Human Normal Immunoglobulin IP (12 mg)- Sodium Thiosulphate IP (32 mg)- Water for Injection IP (. QS)- Stabilizer : Maltose (In House) (7 Percent )- Pack sizes: 1ml in 2 ml Vial /pfs- Benzyl alcohol IP (1 Percent )
21Human Normal Immunoglobulin I.P. 16.5 Percent Protein Content (16.5 Percent W/V)- Stabilizer : Glycine I.P. .. 0.3M (. )- Preservative: Thiomersal I.P. .... 0.01 Percent w/v (. )- Pack Sizes: 1ml, 2ml and 5ml (. )
22Human Prothrombin Complex - 500 IU Human Prothrombin Complex - 500 IU Strength : Each Vial Contains Human Coagulation Factor II - 280-760 IU Human Coagulation Factor VII - 180 - 480 IU Human Coagulation Factor IX - 500 IU Human Coagulation Factor X -360 - 600 IU Protein C - 260-620 IU Protein S - 240-640 IUPacking: Vial
23Insulin Glulisine Prefillied Pen
24Insulin Glulisine Cartrige
25Insulin Glargine 300 IU/ml
26Human Normal Immunoglobulin and Histamine Dihydrochloride Injection PFS Each ml contains:: - Histamine Dihydrochloride BP (0.15 mcg)- Human Normal Immunoglobulin IP (12 mg)- Sodium Thiosulphate IP (32 mg)- Water for Injection IP (. QS)- Stabilizer : Maltose (In House) (7 Percent )- Pack sizes: 1ml in 2 ml Vial /pfs- Benzyl alcohol IP (1 Percent ) (2ml Vial/PFS)
27Human Normal Immunoglobulin I.P. 16.5 Percent Vial Protein Content (16.5 Percent W/V)- Stabilizer : Glycine I.P. .. 0.3M (. )- Preservative: Thiomersal I.P. .... 0.01 Percent w/v (. )- Pack Sizes: 1ml, 2ml and 5ml (. ) Packing: Vial
28Human Prothrombin Complex - 500 IU VialStrength : Each Vial Contains Human Coagulation Factor II - 280-760 IU Human Coagulation Factor VII - 180 - 480 IU Human Coagulation Factor IX - 500 IU Human Coagulation Factor X -360 - 600 IU Protein C - 260-620 IU Protein S - 240-640 IUPacking: Vial
29Anti Hemophilic Factor VIII 250 IU (VWF) Injection
30Anti Hemophilic Factor VIII 500 IU (VWF) Injection
31Anti Hemophilic Factor VIII 1000 IU (VWF) Injection
32Nafithromycin 400mg Tab.
33Nafithromycin 800mg Tab.

AI Tender Summary

OUR REF NO 56486299
AUTHORITY Government Departments
TENDER VALUE Ref. Documents
LAST DATE 04-08-2026
Authority
Authority Name Health And Family Welfare Department
Work Description SUPPLY OF TABLETS, INJECTIONS MISCELLANEOUS ITEMS, YEAR- 2026-27-28 Part 5(Item No1401 TO 1433)- triamcinolone injection 40 mg/ml (1 ml vial), triptorelin pamoate (11.25mg), triptorelin pamoate (22.5mg), trypan blue dye 0.06 percent w/v (1 ml oule), ultra long-acting basal insulin analogue inj (r-dna origin) insulin degludec 100iu/ml in 3ml pfs type of insulin:ultra long acting basa, vasopressin 20 units/ml, 1ml , vecuronium bromide injection 4 mg (iv use) (lyophilized), vedolizumab 300mg, velaglucerase alfa (r-dna origin), verapamil 10 mg, verapamil 5 mg/2 ml, vincristine sulphate lyophilized ip, vinorelbine concentrate, visco elastic substance (hydroxypropyl methyl cellulose ophthalmic solution usp) pfs 2.4 percent w/v 3 ml preservative free, vitamin b complex (for im use), 2 ml oule, vitamin b12 (mecobalamin) 1500 mcg/ml, vitamin b12 500 mcg/ml (cyanocobalamin injection), 1 ml oule, voriconazole 200mg/vial, zolendronic acid injection 4mg, human normal immunoglobulin and histamine dihydrochloride injection each ml contains:: - histamine dihydrochloride bp (0.15 mcg)- human normal immunoglobulin ip (12 mg)- sodium thiosulphate ip (32 mg)- water for injection ip (. qs)- stabilizer : maltose (in house) (7 percent )- pack sizes: 1ml in 2 ml vial /pfs- benzyl alcohol ip (1 percent ), human normal immunoglobulin i.p. 16.5 percent protein content (16.5 percent w/v)- stabilizer : glycine i.p. .. 0.3m (. )- preservative: thiomersal i.p. .... 0.01 percent w/v (. )- pack sizes: 1ml, 2ml and 5ml (. ), human prothrombin complex - 500 iu human prothrombin complex - 500 iu strength : each vial contains human coagulation factor ii - 280-760 iu human coagulation factor vii - 180 - 480 iu human coagulation factor ix - 500 iu human coagulation factor x -360 - 600 iu protein c - 260-620 iu protein s - 240-640 iupacking: vial, insulin glulisine prefillied pen, insulin glulisine cartrige, insulin glargine 300 iu/ml, human normal immunoglobulin and histamine dihydrochloride injection pfs each ml contains:: - histamine dihydrochloride bp (0.15 mcg)- human normal immunoglobulin ip (12 mg)- sodium thiosulphate ip (32 mg)- water for injection ip (. qs)- stabilizer : maltose (in house) (7 percent )- pack sizes: 1ml in 2 ml vial /pfs- benzyl alcohol ip (1 percent ) (2ml vial/pfs), human normal immunoglobulin i.p. 16.5 percent vial protein content (16.5 percent w/v)- stabilizer : glycine i.p. .. 0.3m (. )- preservative: thiomersal i.p. .... 0.01 percent w/v (. )- pack sizes: 1ml, 2ml and 5ml (. ) packing: vial, human prothrombin complex - 500 iu vialstrength : each vial contains human coagulation factor ii - 280-760 iu human coagulation factor vii - 180 - 480 iu human coagulation factor ix - 500 iu human coagulation factor x -360 - 600 iu protein c - 260-620 iu protein s - 240-640 iupacking: vial, anti hemophilic factor viii 250 iu (vwf) injection, anti hemophilic factor viii 500 iu (vwf) injection, anti hemophilic factor viii 1000 iu (vwf) injection, nafithromycin 400mg tab., nafithromycin 800mg tab.
Basic Detail
Tender No 6(2026-27-28 Part 5(Item No1401 TO 1433))
Bidding Type Tender
Location
City Vadodara
State Gujarat
Key Dates
Publish Date 15 Jul 2026
Submission Date 04 Aug 2026
Open Date 01 Jan 0001
Finance
Tender Value Ref. Documents
Tender Fee 5000
EMD 2.50 Lakhs
Exemption Not Available
Document List
TandC20262728.pdf
2e4bb96b666a4617b88117ee46ac9c99.html
LISTOFTABLETSINJECTONSMISCELLANEOUSITEMS.xlsx

Unlock Full AI Tender Summary

Get instant access to the complete AI-generated analysis — scope, eligibility, timeline & more.

Instant Access Secure Free
Your details are secure and used only for document delivery.

Tender Timeline

Jul 15, 2026
11:30 IST

Tender Published

Tender notice published.

Completed
Aug 04, 2026
17:00 IST

Bid Submission Deadline

Online submission via eProcurement portal.

Upcoming · 12 days

Tender Documents

Download All (ZIP) ↓
pdf

TandC20262728.pdf

html

2e4bb96b666a4617b88117ee46ac9c99.html

xlsx

LISTOFTABLETSINJECTONSMISCELLANEOUSITEMS.xlsx

Disclaimer

We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender

TenderDetail
Loading tenders